Skip to content

Pre-oxygenation With High-flow Nasal Cannula in Caesarian Section Under General Anesthesia

Pre-oxygenation With High-flow Nasal Cannula in Pregnant Women Undergoing Caesarian Section Under General Anesthesia - a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04711317
Acronym
PRIOROB
Enrollment
34
Registered
2021-01-15
Start date
2021-03-03
Completion date
2022-11-30
Last updated
2022-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related, Anesthesia, Oxygen Deficiency, Cesarean Section Complications

Keywords

Preoxygenation, Perioxygenation, Nasal high flow oxygen, Cesarian sectio

Brief summary

The investigators and other groups have demonstrated that high-flow nasal oxygen used during preoxygenation for emergency surgery is at least equally effective as preoxygenation compared to standard tight fitting mask. The investigators also have data from a recent study that indicates that high-flow nasal oxygen might decrease the risk of clinically relevant desaturation below 93% of arterial oxygen saturation. The studies investigating the concept of high-flow nasal oxygen has up to this date excluded pregnant women. Pregnant woman is a patient group with known difficulties to maintain adequate saturation levels during apnoea. Due to smaller functional residual capacity their oxygen stores after preoxygenation are smaller compared to patients with a normal body mass index. The pregnant woman also have a higher oxygen demand and metabolism due to the growing placenta and the fetus. Pregnant women are therefore a patient group where a method that could prolong time until desaturation would be even more valuable and potentially could save lives. Based on the above, the investigators now aim to conduct a clinical pilot study, where pregnant women undergoing caesarian section under general anesthesia are pre and perioxygenated with high-flow nasal oxygen. Data from that group will be compared with patients preoxygenated in a traditional manner with tight facemask. This study is done to evaluate an established technique on a patient category that in theory could gain a lot from it.

Interventions

Pregnant women scheduled for cesarian section in general anaesthesia will be preoxygenated using nasal high flow oxygen

Sponsors

Danderyds Hospital, Stockholm, Sweden
CollaboratorUNKNOWN
Stockholm South General Hospital
CollaboratorOTHER
Karlstad Central Hospital
CollaboratorOTHER
Östra Hospital
CollaboratorOTHER
Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

One intervention group that is compared to a control group that is standard treatment.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult, \>18 years old 2. Caesarian section under general anesthesia. 3. Pregnant in week 30 or later 4. Capable of understanding the study information and signing the written consent.

Exclusion criteria

1. BMI \>45 2. Dependency on non-invasive ventilation to maintain oxygen saturation

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with peripheral arterial oxygen saturation below 93% from start of pre-oxygenation until one minute after tracheal intubation and comparison between intervention and controlUp to 1 minute after intubationarterial peripheral oxygen saturation

Secondary

MeasureTime frame
Comparison of Endtidal concentration of oxygen after intubation between intervention and controlThe first breaths after intubation eg. within 20 seconds of intubation
Comparison of Endtidal carbondioxide concentration after intubation between intervention and controlThe first breaths after intubation eg. within 20 seconds of intubation
Comparison of Number of patients with regurgitation of gastric contents between intervention and controlDuring intubation eg up to 0 seconds after intubation

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026